CHDR
Leiden, Netherlands Specialty Founded 1987 51-200 employees
Independent early-phase CRO in the Netherlands specializing in first-in-human and Phase I trials using innovative biomarkers, with a purpose-built 54-bed clinical research unit adjacent to Leiden University Medical Center.
Services
PRECLINICAL
ANALYTICAL
REGULATORY
Therapeutic Areas
Certifications
Regulatory Experience
FDAEMA